Robert Neal Weingarten's most recent trade in Guardion Health Sciences Inc was a trade of 334 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on June 30, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Guardion Health Sciences Inc | Robert Neal Weingarten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 334 | 334 | - | - | Employee Stock Option (right to buy) | |
Lixte Biotechnology Holdin... | Robert Neal Weingarten | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2022 | 200,000 | 200,000 | - | - | Stock Options | |
Guardion Health Sciences Inc | Robert Neal Weingarten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 16,667 | 16,667 | - | - | Employee Stock Option (right to buy) | |
Guardion Health Sciences Inc | Robert Neal Weingarten | Director | Grant, award, or other acquisition of securities at price $ 1.14 per share. | 20 Aug 2021 | 10,000 | 118,750 (0%) | 0% | 1.1 | 11,400 | Common Stock, $0.001 par value |
Guardion Health Sciences Inc | Robert Neal Weingarten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 16,667 | 16,667 | - | - | Employee Stock Option (right to buy) | |
Guardion Health Sciences Inc | Robert Neal Weingarten | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 250,000 | 250,000 | - | - | Stock option (right to buy) | |
Guardion Health Sciences Inc | Robert Neal Weingarten | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 100,000 | 100,000 | - | - | Stock Option |